1 citations
,
October 2022 in “Cureus” This study found that individuals with chronic skin disorders had significantly higher rates of depression and anxiety compared to a control group, though there was no significant difference in their overall quality of life scores.
1 citations
,
February 2022 in “Indian Journal of Nutrition and Dietetics/Indian journal of nutrition and dietetics” This study reported a significant association between cultural dress practices, reduced sunlight exposure, and symptoms of vitamin D and calcium deficiency among Muslim women in Coimbatore.
1 citations
,
January 2022 in “Turkiye Klinikleri Journal of Dermatology” This study observed shifts in dermatological disease frequencies amid early COVID-19 pandemic lifestyle changes, noting significant increases in urticaria, drug eruptions, and alopecia areata, while bacterial and fungal infections decreased.
1 citations
,
January 2021 in “Clinical dermatology review” This study found that patients with androgenic alopecia rated their hair loss as more severe than dermatologists did, affecting their quality of life significantly.
1 citations
,
March 2019 in “American journal of geriatric psychiatry/The American journal of geriatric psychiatry” This case study highlights the challenges inpatient psychiatric teams face in managing end-of-life care for patients with advanced Alzheimer's, particularly in honoring DNR/DNI orders and coordinating hospice transfers.
1 citations
,
April 2018 in “Rheumatology” This study found that 59.7% of lupus patients self-reported alopecia, which was linked to anti-Ro antibody presence and cutaneous SLE symptoms but not to age, ethnicity, or medication.
1 citations
,
January 2018 in “Dermatology Online Journal” This article highlights the importance of discussing the possible duration of skin conditions with patients but reports no new research findings.
1 citations
,
January 2017 in “Journal of Community & Public Health Nursing” In this study, no significant link was found between cap-wearing habits and quality of life in Indian males over 50 with androgenic alopecia, but more severe alopecia was associated with a poorer quality of life.
1 citations
,
January 2017 in “Endokrynologia Pediatryczna” This review concludes that polycystic ovary syndrome can significantly impact aspects of health-related quality of life in adolescent girls, especially body image and interpersonal functioning.
1 citations
,
April 2016 in “Journal of The American Academy of Dermatology” Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.
1 citations
,
November 2015 in “Journal of Clinical Dermatology” This study found that among Korean patients with pattern hair loss, the subjective severity of hair loss and socio-psychological stress influenced their expenditure and quality of life, rather than the clinical severity.
1 citations
,
August 2000 in “Expert Opinion on Therapeutic Patents” This article reviews the therapeutic use of carnitine derivatives for re-establishing mitochondrial functionality in aging and reports no new clinical results.
July 2026 in “Frontiers in Medicine” This study describes a new treatment algorithm for alopecia areata that includes both disease severity and quality-of-life considerations, highlighting recent therapeutic advances and the need for future validation and access equity.
This study successfully adapted the Alopecia Areata Quality of Life Index Questionnaire into Turkish, finding it to be valid and reliable for assessing the quality of life in Turkish patients with alopecia areata.
June 2026 in “Drugs & Therapy Perspectives” This study reports that patients with severe alopecia areata who experienced sustained scalp regrowth while receiving continuous baricitinib treatment showed improvements in health-related quality of life and reductions in anxiety and depression symptoms.
June 2026 in “npj Digital Medicine” This systematic review found that digital health interventions may improve quality of life for dermatology patients, especially through telemedicine, which often matched or exceeded in-person care. However, the evidence is limited by study variability and short follow-up periods.
June 2026 in “Journal of Cosmetic Dermatology” In this study, digital treatment for androgenetic alopecia over six months led to significant improvements in quality of life among Brazilian men, particularly for those with consistent program adherence, although the absence of an in-person comparator limits causal conclusions.
May 2026 in “Frontiers in Reproductive Health” This narrative review reported that a variety of lifestyle-based interventions, such as specific dietary changes and physical activity, along with adjunctive therapies, have potential benefits in managing metabolic and hormonal outcomes in women with PCOS, although the variable study quality suggests further research is needed.
May 2026 in “Pacific Rim International Journal of Nursing Research” In this study of Thai women with ovarian cancer receiving chemotherapy, researchers found that symptom experiences such as numbness, tingling, and fatigue were frequent and significantly affected quality of life, while the effectiveness of symptom management did not significantly predict quality of life.
May 2026 in “International Journal of Drug Delivery Technology” This study reports that using machine learning models, particularly XGBoost and Random Forest, can accurately predict PCOS phenotypes based on non-invasive data, with cycle length as the most significant predictor.
May 2026 in “Nursing Reports” This study found that Slovak breast cancer survivors experience moderate overall quality of life, with variations across domains linked to treatment types and sociodemographic factors, pointing to the need for tailored supportive care.
April 2026 in “ScholarWorks (Walden University)” This phenomenological study reported that Malaysian women with PCOS experience significant emotional, social, and physical challenges affecting their quality of life, highlighting the need for improved patient-centered care.
April 2026 in “Pediatric Dermatology” This review analyzes quality of life instruments for pediatric alopecia areata and reports inconsistencies in their coverage, suggesting the need for new tools to comprehensively assess all affected life aspects.
In a phase 2 trial, researchers tested a topical formulation for alopecia areata and found significant hair regrowth with the treatment, but these improvements did not lead to substantial enhancements in health-related quality of life.
March 2026 in “Ukrains kyi Visnyk Psykhonevrolohii” In this study, female patients with mixed alopecia reported significantly lower quality of life compared to those with metabolic alopecia, with poorer psychological well-being and personal fulfillment, linked closely to mental maladaptation severity, suggesting a biopsychosocial treatment approach.
March 2026 in “Endocrine Metabolic & Immune Disorders - Drug Targets” This study found that in women with PCOS, a combination of finasteride and spironolactone significantly improved all health-related quality of life scales and reduced hyperandrogenism within four months, supporting its role alongside lifestyle measures.
March 2026 in “Dermatology and Therapy” In this study, researchers found that patients with severe alopecia areata often experience reduced health-related quality of life, with significant levels of anxiety and depression, and these mental health impacts may correlate with the severity of their condition.
March 2026 in “Advanced medical journal” This retrospective study in Duhok, Iraq, found that a minimal incision temporal brow lift achieved higher satisfaction rates in women and patients under local anesthesia, though complications like chronic postoperative pain occurred. Further research is needed to assess long-term efficacy of this brow elevation method.
March 2026 in “Anais Brasileiros de Dermatologia” Facial aesthetic procedures improve quality of life for transgender individuals.
February 2026 in “PubMed” This study found that among women with female pattern hair loss, low-dose oral minoxidil improved hair loss severity and quality of life scores despite 71.6% experiencing mild to moderate unwanted hair growth, which most patients did not consider a reason to discontinue treatment.